Neuroagetx
Founded 2022 · 14 employees on LinkedIn · 1 known investors
Find your way into Neuroagetx
422 people in our graph share verified history with the Neuroagetx team — schools, employers, funds. One of them is your warm intro.
Lou Segallunlockedknows Christin Glorioso · together at Massachusetts Institute of Technology (overlapped)
×11knows the team · via Massachusetts Institute of Technology
NeuroAge offers multi-modal brain health testing that combines cognitive games, volumetric MRI, whole-genome sequencing, and blood biomarker tests to measure "brain age" and dementia risk for individuals concerned about neurodegenerative disease. It provides a unified dashboard, personalized recommendations, and brain training aimed at early detection of Alzheimer's and cognitive decline.
Founders & leadership
Neuroagetx was founded in 2022 by Christin Glorioso.
CG
Christin GloriosoinFounder (MD, PhD)Christin Glorioso is an MIT-trained neuroscientist and physician who previously led research at the DICE Institute, where she developed epidemiological prediction models during the COVID-19 pandemic. She is founder of NeuroAge Therapeutics, which develops brain health assessment tools using neuroimaging, genomic sequencing, and biomarkers to evaluate cognitive aging and dementia risk.
Investors · 1
Frequently asked questions
- What does Neuroagetx do?
- NeuroAge offers multi-modal brain health testing that combines cognitive games, volumetric MRI, whole-genome sequencing, and blood biomarker tests to measure "brain age" and dementia risk for individuals concerned about neurodegenerative disease. It provides a unified dashboard, personalized recommendations, and brain training aimed at early detection of Alzheimer's and cognitive decline.
- Who founded Neuroagetx?
- Neuroagetx was founded by Christin Glorioso in 2022.
- Who are Neuroagetx's investors?
- Neuroagetx's investors include IA Seed Ventures.